Therapeutic Approach

Archive: January, 2018

Ritter Pharmaceuticals Appoints Diane J. Plotkin as Vice President of Clinical Development, Ahead of the Launch of its Phase 3 Clinical Trial

LOS ANGELES (January 29, 2018) – Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutics that modulate the human gut microbiome to treat gastrointestinal diseases, today announced the appointment of Diane J. Plotkin, Ph.D., as Vice President of Clinical Development. Dr. Plotkin joins Ritter Pharmaceuticals with nearly thirty years […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD